Related Experiment Video
Updated: Aug 5, 2026
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Altered IRF1-miR-20a-5p regulatory axis in the hippocampus of patients with major depressive disorder
Mariko Okano1, Yuta Yoshino1, Anuj K Verma2
1Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Japan.
Aim:
Neuroinflammation has been implicated in the pathogenesis of major depressive disorder (MDD), with interferon regulatory factor 1 (IRF1) playing a potential role. MicroRNAs (miRs) are also involved in MDD through posttranscriptional regulation of gene expression. This study investigated whether miR-20a-5p regulates IRF1 in MDD.
Methods:
IRF1 mRNA and miR-20a-5p expression levels were measured by qPCR in postmortem hippocampi from 14 MDD subjects and 14 controls, and in chronic social defeat stress (CSDS) mice. Their regulatory relationship was examined in HEK293 cells using miR-20a-5p overexpression and a dual-luciferase assay. Neuro2a cells treated with DMSO were used to evaluate the effects of cellular stress on Irf1 and miR-20a-5p expression.
Results:
IRF1 mRNA and miR-20a-5p expression levels were significantly increased in both MDD hippocampi and CSDS mice. Luciferase assays showed that miR-20a-5p directly targeted the conserved seed sequence within the IRF1 3'-UTR and suppressed IRF1 expression. During the early phase of cellular stress, Irf1 mRNA was upregulated, whereas miR-20a-5p was downregulated, suggesting that stress initially induces Irf1 expression, followed by secondary regulation of miR-20a-5p.
Conclusion:
IRF1 mRNA expression was increased in the hippocampus of both MDD subjects and CSDS mice. Moreover, miR-20a-5p directly targeted the IRF1 3'-UTR, supporting a potential miR-20a-5p-IRF1 regulatory axis involved in inflammatory signaling in MDD. However, its functional significance in vivo remains to be determined.
Insights
Major depressive disorder (MDD) involves neuroinflammation, with interferon regulatory factor 1 (IRF1) and microRNAs (miRs) playing roles. This study found miR-20a-5p directly targets and regulates IRF1 in MDD.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Neuroinflammation is a key factor in major depressive disorder (MDD) pathogenesis.
- Interferon regulatory factor 1 (IRF1) and microRNAs (miRs) are implicated in MDD.
- The specific regulatory relationship between miRs and IRF1 in MDD requires elucidation.
Purpose of the Study:
- To investigate the regulatory role of miR-20a-5p on IRF1 expression in the context of MDD.
- To explore the potential involvement of a miR-20a-5p-IRF1 axis in MDD-related inflammatory signaling.
Main Methods:
- Quantitative PCR (qPCR) to measure IRF1 mRNA and miR-20a-5p levels in human MDD hippocampi and CSDS mouse models.
- Dual-luciferase reporter assays in HEK293 cells to confirm direct targeting of IRF1 by miR-20a-5p.
- Cellular stress models (Neuro2a cells) to assess dynamic expression changes.
Main Results:
- Both IRF1 mRNA and miR-20a-5p expression were significantly elevated in MDD hippocampi and CSDS mice.
- miR-20a-5p was confirmed to directly bind to the IRF1 3'-UTR, inhibiting its expression.
- Cellular stress initially upregulated IRF1, followed by a downregulation of miR-20a-5p, indicating a feedback mechanism.
Conclusions:
- A significant increase in IRF1 mRNA was observed in the hippocampus of MDD subjects and CSDS mice.
- miR-20a-5p directly targets IRF1, suggesting a novel regulatory axis potentially contributing to MDD pathophysiology.
- Further in vivo studies are necessary to determine the precise functional significance of this miR-20a-5p-IRF1 interaction in MDD.
